What is ACTU stock price today?

Visit our real-time dashboard for the current ACTU stock price and live market data.

Is ACTU stock going up or down today?

ACTU stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACTU stock now?

The decision to buy ACTU depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACTU a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACTU based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACTU stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACTU is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACTU's P/E ratio?

P/E ratio data for ACTU will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACTU's market cap?

ACTU (Actuate Therapeutics, Inc. Common stock) has a market capitalization of $0.05 billion, making it a small-cap stock.

What is ACTU's price to book ratio?

ACTU trades at a price-to-book (P/B) ratio of 12.90, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACTU pay dividends?

ACTU does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACTU's dividend yield?

ACTU does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACTU stock a good long-term investment?

ACTU's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACTU's revenue growth rate?

Revenue growth data for ACTU is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACTU are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACTU?

Key risks for ACTU include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACTU compare to its competitors?

Compare ACTU to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACTU's performance and positioning.

What is ACTU's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ACTU with bull, base, and bear case scenarios.

What do analysts say about ACTU?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACTU. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACTU's next earnings report?

ACTU reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACTU - Actuate Therapeutics, Inc. Common stock

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Actuate Therapeutics, Inc. Common stock

Actuate Therapeutics, Inc. Common stock (ACTU) common stock

Price Chart

Loading chart...

ACTU Key Statistics

Market Cap

$49.05M

P/B Ratio

12.90

How ACTU Compares to Peers

ACTU is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACTU(This stock)	$49.05M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 20, 2026 at 6:47 PM EDT

Ready to invest in ACTU?

Commission-free trading available. Affiliate links.

ACTU Lician Score

5% confidence

4.0/10

Neutral

ACTU has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACTUacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACTU Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACTU

Dashboard

Enter a ticker to analyze